PharmaDeals Research: Outsourcing of Deal Making Analysis




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: PharmaDeals Research: Outsourcing of Deal Making Analysis
Released on: August 01, 2007. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this special feature interview, Fintan Walton talks with John Wyatt, Head of Commercial Development at PharmaVentures, about PharmaVentures' new service - PharmaDeals Research.
  • Summary
  • Participants
  • Company
In this special feature interview, Fintan Walton talks with John Wyatt, Head of Commercial Development at PharmaVentures, about PharmaVentures' new service - PharmaDeals Research. John explains that PharmaDeals Research was launched to complement PharmaDeals Agreements in response to frequent customer requests for help with their deal-related research. These requests, John explains, were frequently from licensing executives who were too busy to carry out their own research and were looking for cost-effective information with a rapid turn-around. In particular, the service has been designed to fit between the PharmaDeals Agreements deals database, and the consultancy services offered by PharmaVentures.

They discuss the interest to date, which has ranged from small biotechs who quickly need one-off pieces of research, through to big pharma companies who are looking for retained, out-sourced analytical services.
John Wyatt has nearly thirty years experience working within and serving the needs of the Life Science Industry. As a practicing medicinal chemist, John developed his career at the Wellcome Foundation to become Department Head of Physical Chemistry. During that time, he was responsible for a contribution to a number of patents and publications.

For the last fifteen years John has developed a diverse business career. Prior to his current position at PharmaVentures as Head of Commercial Development, he worked in a senior Business Development role for Applied Biosystems, and prior to this position as European Managing Director for Paracel, a Biotechnology business based in Pasadena, California. John has a PhD in organic chemistry and studied business at the Open University, to obtain an MBA in 2002.
PharmaVentures Ltd
PharmaVentures is a company that has proven success in deals and alliances.

PharmaVentures offers:


• Over 18 years of healthcare industry experience

• Experience gained from working with in excess of 1000 clients in 38 countries, and conducting more than 450 assignments

• Over 40 specialist advisors, analysts and researchers

• Skills honed in many countries - 80% of its business comes from outside the UK